< Back to situations

[ORGANIZATION]

Saudi Food and Drug Authority

Featured in 4 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [CN] [SA]

Retatrutide investigational drug development and safety

4 clusters · 9 sources · last updated

Latest: Saudi FDA warns against unapproved use of Retatrutide

Retatrutide, an investigational synthetic peptide developed by Eli Lilly (also known by the code LY3437943), is being studied for its metabolic potential in managing food regulation, sugar, and weight. As a triple recept

Also covered in